Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
Identifieur interne : 000620 ( Main/Exploration ); précédent : 000619; suivant : 000621Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
Auteurs : Alessandro Lucchesi [Italie] ; Paolo Silimbani [Italie] ; Gerardo Musuraca [Italie] ; Claudio Cerchione [Italie] ; Giovanni Martinelli [Italie] ; Paola Di Carlo [Italie] ; Mariasanta Napolitano [Italie]Source :
- Journal of medical virology [ 1096-9071 ] ; 2021.
Descripteurs français
- KwdFr :
- MESH :
- génétique : Protéine-3 de la famille des NLR contenant un domaine pyrine.
- pharmacologie : Hydroxychloroquine.
- Humains, Inflammasomes.
English descriptors
- KwdEn :
- MESH :
- chemical , genetics : NLR Family, Pyrin Domain-Containing 3 Protein.
- chemical , pharmacology : Hydroxychloroquine.
- drug therapy : COVID-19.
- Humans, Inflammasomes, SARS-CoV-2.
DOI: 10.1002/jmv.26217
PubMed: 32579244
PubMed Central: PMC7361389
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.</title><author><name sortKey="Lucchesi, Alessandro" sort="Lucchesi, Alessandro" uniqKey="Lucchesi A" first="Alessandro" last="Lucchesi">Alessandro Lucchesi</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Silimbani, Paolo" sort="Silimbani, Paolo" uniqKey="Silimbani P" first="Paolo" last="Silimbani">Paolo Silimbani</name><affiliation wicri:level="1"><nlm:affiliation>Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Musuraca, Gerardo" sort="Musuraca, Gerardo" uniqKey="Musuraca G" first="Gerardo" last="Musuraca">Gerardo Musuraca</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Cerchione, Claudio" sort="Cerchione, Claudio" uniqKey="Cerchione C" first="Claudio" last="Cerchione">Claudio Cerchione</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Martinelli, Giovanni" sort="Martinelli, Giovanni" uniqKey="Martinelli G" first="Giovanni" last="Martinelli">Giovanni Martinelli</name><affiliation wicri:level="1"><nlm:affiliation>Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Di Carlo, Paola" sort="Di Carlo, Paola" uniqKey="Di Carlo P" first="Paola" last="Di Carlo">Paola Di Carlo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Health Promotion, Mother, and Child Care, Internal Medicine and Medical Specialties and Infectious Disease Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Health Promotion, Mother, and Child Care, Internal Medicine and Medical Specialties and Infectious Disease Unit, University Hospital "P. Giaccone", University of Palermo, Palermo</wicri:regionArea><wicri:noRegion>Palermo</wicri:noRegion></affiliation></author><author><name sortKey="Napolitano, Mariasanta" sort="Napolitano, Mariasanta" uniqKey="Napolitano M" first="Mariasanta" last="Napolitano">Mariasanta Napolitano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties and Haematology Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties and Haematology Unit, University Hospital "P. Giaccone", University of Palermo, Palermo</wicri:regionArea><wicri:noRegion>Palermo</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:32579244</idno><idno type="pmid">32579244</idno><idno type="doi">10.1002/jmv.26217</idno><idno type="pmc">PMC7361389</idno><idno type="wicri:Area/Main/Corpus">001308</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001308</idno><idno type="wicri:Area/Main/Curation">001308</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001308</idno><idno type="wicri:Area/Main/Exploration">001308</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.</title><author><name sortKey="Lucchesi, Alessandro" sort="Lucchesi, Alessandro" uniqKey="Lucchesi A" first="Alessandro" last="Lucchesi">Alessandro Lucchesi</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Silimbani, Paolo" sort="Silimbani, Paolo" uniqKey="Silimbani P" first="Paolo" last="Silimbani">Paolo Silimbani</name><affiliation wicri:level="1"><nlm:affiliation>Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Musuraca, Gerardo" sort="Musuraca, Gerardo" uniqKey="Musuraca G" first="Gerardo" last="Musuraca">Gerardo Musuraca</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Cerchione, Claudio" sort="Cerchione, Claudio" uniqKey="Cerchione C" first="Claudio" last="Cerchione">Claudio Cerchione</name><affiliation wicri:level="1"><nlm:affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Martinelli, Giovanni" sort="Martinelli, Giovanni" uniqKey="Martinelli G" first="Giovanni" last="Martinelli">Giovanni Martinelli</name><affiliation wicri:level="1"><nlm:affiliation>Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena</wicri:regionArea><wicri:noRegion>Forlì-Cesena</wicri:noRegion></affiliation></author><author><name sortKey="Di Carlo, Paola" sort="Di Carlo, Paola" uniqKey="Di Carlo P" first="Paola" last="Di Carlo">Paola Di Carlo</name><affiliation wicri:level="1"><nlm:affiliation>Department of Health Promotion, Mother, and Child Care, Internal Medicine and Medical Specialties and Infectious Disease Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Health Promotion, Mother, and Child Care, Internal Medicine and Medical Specialties and Infectious Disease Unit, University Hospital "P. Giaccone", University of Palermo, Palermo</wicri:regionArea><wicri:noRegion>Palermo</wicri:noRegion></affiliation></author><author><name sortKey="Napolitano, Mariasanta" sort="Napolitano, Mariasanta" uniqKey="Napolitano M" first="Mariasanta" last="Napolitano">Mariasanta Napolitano</name><affiliation wicri:level="1"><nlm:affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties and Haematology Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties and Haematology Unit, University Hospital "P. Giaccone", University of Palermo, Palermo</wicri:regionArea><wicri:noRegion>Palermo</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of medical virology</title><idno type="eISSN">1096-9071</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (drug therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (pharmacology)</term><term>Inflammasomes (MeSH)</term><term>NLR Family, Pyrin Domain-Containing 3 Protein (genetics)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains (MeSH)</term><term>Hydroxychloroquine (pharmacologie)</term><term>Inflammasomes (MeSH)</term><term>Protéine-3 de la famille des NLR contenant un domaine pyrine (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>NLR Family, Pyrin Domain-Containing 3 Protein</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Protéine-3 de la famille des NLR contenant un domaine pyrine</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Inflammasomes</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Inflammasomes</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32579244</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>01</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.</ArticleTitle><Pagination><MedlinePgn>124-126</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.26217</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lucchesi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0624-5311</Identifier><AffiliationInfo><Affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silimbani</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musuraca</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerchione</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinelli</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Scientific Directorate, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Carlo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Health Promotion, Mother, and Child Care, Internal Medicine and Medical Specialties and Infectious Disease Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napolitano</LastName><ForeName>Mariasanta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties and Haematology Unit, University Hospital "P. Giaccone", University of Palermo, Palermo, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Med Virol. 2020 Jul;92(7):776-785</RefSource><PMID Version="1">32297988</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Med Virol. 2021 Feb;93(2):669-670</RefSource><PMID Version="1">32841451</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="Y">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32579244</ArticleId><ArticleId IdType="doi">10.1002/jmv.26217</ArticleId><ArticleId IdType="pmc">PMC7361389</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Sarma P, Kaur H, Kumar H, et al. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: a systematic review and meta-analysis. J Med Virol. 2020;92(7):776-785. https://doi.org/10.1002/jmv.25898</Citation></Reference><Reference><Citation>He L, Ding Y, Zhang Q, et al. Expression of elevated levels of proinflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006;210(3):288-297. https://doi.org/10.1002/path.2067</Citation></Reference><Reference><Citation>Wang Z, Zhang S, Xiao Y, et al. NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev. 2020;2020:4063562. https://doi.org/10.1155/2020/4063562</Citation></Reference><Reference><Citation>Hosseinian N, Cho Y, Lockey RF, Kolliputi N. The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis. 2015;9(4):188-197. https://doi.org/10.1177/1753465815586335</Citation></Reference><Reference><Citation>Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10:40. https://doi.org/10.1186/s13578-020-00404-4</Citation></Reference><Reference><Citation>Zhao C, Zhao W. NLRP3 inflammasome-A key player in antiviral responses. Front Immunol. 2020;11:211. https://doi.org/10.3389/fimmu.2020.00211</Citation></Reference><Reference><Citation>Grailer JJ, Canning BA, Kalbitz M, et al. Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol. 2014;192(12):5974-5983. https://doi.org/10.4049/jimmunol.1400368</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Lucchesi, Alessandro" sort="Lucchesi, Alessandro" uniqKey="Lucchesi A" first="Alessandro" last="Lucchesi">Alessandro Lucchesi</name></noRegion><name sortKey="Cerchione, Claudio" sort="Cerchione, Claudio" uniqKey="Cerchione C" first="Claudio" last="Cerchione">Claudio Cerchione</name><name sortKey="Di Carlo, Paola" sort="Di Carlo, Paola" uniqKey="Di Carlo P" first="Paola" last="Di Carlo">Paola Di Carlo</name><name sortKey="Martinelli, Giovanni" sort="Martinelli, Giovanni" uniqKey="Martinelli G" first="Giovanni" last="Martinelli">Giovanni Martinelli</name><name sortKey="Musuraca, Gerardo" sort="Musuraca, Gerardo" uniqKey="Musuraca G" first="Gerardo" last="Musuraca">Gerardo Musuraca</name><name sortKey="Napolitano, Mariasanta" sort="Napolitano, Mariasanta" uniqKey="Napolitano M" first="Mariasanta" last="Napolitano">Mariasanta Napolitano</name><name sortKey="Silimbani, Paolo" sort="Silimbani, Paolo" uniqKey="Silimbani P" first="Paolo" last="Silimbani">Paolo Silimbani</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000620 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000620 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32579244
|texte= Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32579244" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |